RecruitingNCT07288567
What is this study about?Researchers are comparing KarXT and placebo to find out how the approaches affect psychotic symptoms in young people with schizophrenia.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 13–17
- Countries
- United States, Colombia, Japan, + 1 other
- Sponsor
- Bristol-Myers Squibb (Pharmaceutical company)
RecruitingNCT06882785
What is this study about?This study evaluates the safety and effectiveness of KarXT for people with schizophrenia.
Multiple locations, including KōnanSchizophreniaMedication studyAges 18–65
- Countries
- Japan
- Sponsor
- Bristol-Myers Squibb (Pharmaceutical company)
RecruitingNCT07061288
What is this study about?This study evaluates the safety of KarXT for people with schizophrenia.
Multiple locations, including Los AlamitosSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Bristol-Myers Squibb (Pharmaceutical company)
RecruitingNCT07428460
Official study titleAccelerated, Neuronavigated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
In VerdunSchizophreniaDevice studyAges 18–65
- Countries
- Canada
- Sponsor
- Douglas Mental Health University Institute
RecruitingNCT04887792
Official study titleA Randomized Controlled Trial of Acetazolamide for Patients With Treatment Resistant Schizophrenia
Multiple locations, including PittsburghSchizophreniaMedication studyAges 18–55
- Countries
- United States, India
- Sponsor
- Vishwajit Nimgaonkar, MD PhD
RecruitingNCT05823532
Official study titleTargeting Inflammation-Induced Changes in Brain Reward Signaling and Motivational Deficits in Patients With Schizophrenia Using an Anti-Inflammatory Challenge.
In AtlantaSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Emory University
RecruitingNCT06969755
Multiple locations, including BirminghamSchizophreniaMedication studyAges 18–35
- Countries
- United States, Canada
- Sponsor
- Northwell Health
RecruitingNCT05276050
In HoustonSchizophrenia, AddictionDevice studyAges 22–65
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
RecruitingNCT06749444
In Glostrup, DenmarkSchizophreniaInterventional studyAges 18–64
- Countries
- Denmark
- Sponsor
- Jimmi Nielsen
RecruitingNCT04917302
In TaichungSchizophreniaMedication studyAges 18–65
- Countries
- Taiwan
- Sponsor
- China Medical University Hospital
RecruitingNCT05240976
In TaichungSchizophreniaMedication studyAges 18–65
- Countries
- Taiwan
- Sponsor
- China Medical University Hospital
RecruitingNCT04959201
In TaichungSchizophreniaMedication studyAges 18–65
- Countries
- Taiwan
- Sponsor
- China Medical University Hospital
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
Get research updates
